# Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

> **NCT02078440** · PHASE1 · COMPLETED · sponsor: **VeroScience** · enrollment: 18 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Bromocriptine mesylate

## Key facts

- **NCT ID:** NCT02078440
- **Lead sponsor:** VeroScience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078440, "Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02078440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*